For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240321:nRSU8578Ha&default-theme=true
RNS Number : 8578H Avingtrans PLC 21 March 2024
21 March 2024
Avingtrans Plc
("Avingtrans", the "Company", or the "Group")
Exercise of Options, PDMR Dealings and Total Voting Rights
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, announces transactions involving its shares by certain
PDMRs and other employees pursuant to the Company Share Option plan ("CSOP").
On 20 March 2024, the Company was notified of the exercise of 192,400 CSOP
options over ordinary shares of 5p each in the Company ("Ordinary Shares")
pursuant to the Company's FY 2019 CSOP and FY 2020 CSOP.
Details of the exercise of options by PDMRs, together with subsequent
beneficial holdings of each individual following the transactions, are set out
below:
PDMR / Role CSOP options exercised Beneficial interest in Ordinary Shares following the transactions Resulting percentage holding of Enlarged Total Voting Rights held
Stephen King (CFO) 10,400 417,338 1.27%
Austen Adams (MD, Process Solutions & Rotating Equipment) 110,000 263,135 0.80
Issue of Equity
Application has been made for the admission to trading on AIM for the
192,400 new Ordinary Shares ("Admission"). It is expected that Admission will
become effective on 26 March 2024.
Total Voting Rights
Following the issue of the 192,400 new Ordinary Shares, the Company will have
a total of 33,089,922 Ordinary Shares in issue. The Company does not hold any
shares in Treasury.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
The above information is provided by the Company in accordance with its
obligations under the FCA's Disclosure Guidance and Transparency Rules.
ENDS
Enquiries:
Avingtrans plc 01354 692391
Les Thomas, Interim Chairman
Steve McQuillan, Chief Executive Officer
Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker) 02074 963000
Shaun Dobson
Alex Bond
Oliver Platts
IFC Advisory (Financial PR) 020 3934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and
associated aftermarket services to the energy, medical and industrial markets
worldwide.
Business units
Hayward Tyler - Luton, East Kilbride & Nottingham, UK, USA, China and
India
Specialises in the design, manufacture and servicing of performance-critical
motors and pumps for challenging environments.
Energy Steel, Inc - Rochester Hills, Michigan, USA
Provider of custom fabrications for the nuclear industry, specialising in: OEM
parts obsolescence; custom fabrications; engineering design solutions; product
refurbishment; on-site technical support.
Stainless Metalcraft Ltd - Chatteris, UK
Provider of safety-critical equipment for the energy, medical, science and
research communities, worldwide, specialising in precision pressure and vacuum
vessels and associated fabrications, sub-assemblies and systems.
Booth Industries - Bolton, UK
Designs, manufactures, installs and services doors and walls which can be
tailored to be: blast and explosion proof; fireproof; acoustically shielded;
high security/safety; or combinations of the above.
Ormandy Group - Bradford, UK
Design, manufacturers and servicing of off-site plant, heat exchangers and
other HVAC (heating, ventilation and air conditioning) products.
Composite Products Ltd - Buckingham, UK
Centre for composite technology, parts and assemblies, serving customers in
industrial markets.
Adaptix Ltd - Oxford, UK
Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary
applications amongst others. Commercialisation of this system (and others) is
on-going.
Magnetica Ltd - Brisbane, Australia
Magnetica Limited specialises in the development of next generation MRI
technologies, including dedicated extremity MRI systems and MRI system
components. Magnetica has successfully built and tested a compact, integrated
3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging.
Commercialisation of this system (and others) is on-going. Magnetica's
structure now includes two other business units:
Scientific Magnetics - Abingdon, UK
Designs and manufactures superconducting magnet systems and associated
cryogenics for a variety of markets including MRI and provides services for
Nuclear Magnetic Resonance instruments.
Tecmag Inc - Houston, USA
Designs, manufactures and installs instrumentation, including consoles, system
upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear
Magnetic Resonance (NMR) systems.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Steve King
2 Reason for the notification
a) Position/status CFO
Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avingtrans PLC
b) LEI 213800ZZ96CKPI423E86
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument CSOP Option Awards over Ordinary Shares of 5p each
Identification code ISIN: GB0009188797
b) Nature of the transaction Exercise of Options under the CSOP
c) Price(s) and volume(s)
Price(s) Volume(s)
267p 10,400
d) Aggregated information n/a
- Aggregated volume
- Price
e) Date of the transaction 20 March 2024
f) Place of the transaction Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
20 March 2024
f)
Place of the transaction
Off market
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Austen Adams
2 Reason for the notification
a) Position/status MD, Process Solutions & Rotating Equipment
Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avingtrans PLC
b) LEI 213800ZZ96CKPI423E86
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument CSOP Option Awards over Ordinary Shares of 5p each
Identification code ISIN: GB0009188797
b) Nature of the transaction Exercise of Options under the CSOP
c) Price(s) and volume(s)
Price(s) Volume(s)
267p 110,000
d) Aggregated information n/a
- Aggregated volume
- Price
e) Date of the transaction 20 March 2024
f) Place of the transaction Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
20 March 2024
f)
Place of the transaction
Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
20 March 2024
f)
Place of the transaction
Off market
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Austen Adams
2 Reason for the notification
a) Position/status MD, Process Solutions & Rotating Equipment
Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avingtrans PLC
b) LEI 213800ZZ96CKPI423E86
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument CSOP Option Awards over Ordinary Shares of 5p each
Identification code ISIN: GB0009188797
b) Nature of the transaction Exercise of Options under the CSOP
c) Price(s) and volume(s)
Price(s) Volume(s)
267p 110,000
d) Aggregated information n/a
- Aggregated volume
- Price
e) Date of the transaction 20 March 2024
f) Place of the transaction Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
20 March 2024
f)
Place of the transaction
Off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFERVTILFIS